Research | OneLook Acronym Finder |
Serial Number | 85959221 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Michelle L. Visser |
Attorney Name | Michelle L. Visser |
Attorney Docket Number | 66569-0029 |
Law Office Assigned | L20 |
Employee Name | REEVES, APRIL ELIZABET |
2013-06-13 | Application Filed |
2014-05-13 | Published for Opposition |
2015-09-21 | Abandon |
2015-09-21 | Location: TTAB |
2015-09-21 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | GW Pharma Limited |
Address | Porton Down Science Park Salisbury GB SP4OJR |
Legal Entity Type | Corporation |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, bladder disfunction, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse; herb teas for medicinal purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2013-06-17 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2013-06-21 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2013-09-15 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2013-09-19 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2013-09-19 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2013-09-19 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-03-18 | 7 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2014-03-31 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-04-07 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-04-07 | 10 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-04-08 | 11 CNSA P: |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2014-04-10 | 12 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2014-04-23 | 13 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2014-05-13 | 14 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2014-05-13 | 15 NPUB E:E-Mail |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2014-06-11 | 16 ETOF T:TTAB Proceeding |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2014-11-06 | 17 EPPA I:Incoming Correspondence |
OPPOSITION INSTITUTED NO. 999999 | 2014-11-10 | 18 OP.I T:TTAB Proceeding |
ASSIGNED TO PETITION STAFF | 2014-11-12 | 19 APET A:Allowance for Publication |
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2014-11-13 | 20 CHPB I:Incoming Correspondence |
OPPOSITION SUSTAINED NO. 999999 | 2015-09-21 | 21 OP.S T:TTAB Proceeding |
OPPOSITION TERMINATED NO. 999999 | 2015-09-21 | 22 OP.T T:TTAB Proceeding |
ABANDONMENT - AFTER INTER PARTES DECISION | 2015-09-21 | 23 ABN4 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | 2015-09-21 | 24 MAB4 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.